Patcho, Ermel B.

HRN: 20-57-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2024
CO-AMOXICLAV 625MG (TAB)
08/26/2024
09/02/2024
PO
625mg
Q8H
Avulsed Wound, Palms And Soles
Waiting Final Action 
08/26/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/26/2024
09/02/2024
TOPICAL
-
Q 24H
Partial Thickness Burns, Palms And Soles
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: